de Toledo Carlos Fischer, Carvente Claudia Teresa, Shigueoka David Carlos, Borges Durval Rosa
Department of Medicine, Universidade Federal de São Paulo (UNIFESP), Sao Paulo, Brazil.
Dig Dis Sci. 2009 Jun;54(6):1331-6. doi: 10.1007/s10620-008-0475-8. Epub 2008 Aug 27.
To evaluate the serum levels of von Willebrand factor (vWF), vascular endothelial growth factor (VEGF), endothelin-1 (ET-1), and endothelin-3 (ET-3) in patients with the isolated, inactive form of Schistosomiasis mansoni. Patients were classified into two groups: 10 patients without (SM group) and 18 with (PH group) portal hypertension.
Serum albumin, VEGF, and vWF levels did not differ between the two groups (P > 0.05). The prothrombin time (INR), number of platelets, spleen size, splenic vein diameter, and endothelin levels differentiated the PH group, which showed decreased ET-1 (SM = 22.4 +/- 2.4 pg/ml and PH = 16.4 +/- 1.5 pg/ml; P = 0.034) and increased ET-3 (SM = 2.1 +/- 0.1 ng/ml and PH = 3.2 +/- 0.1 ng/ml; P = 0.000) levels.
In patients with schistosomiasis and portal hypertension (presinusoidal type), the levels of VEGF and ET-1 differ from those reported in patients with cirrhosis.
评估曼氏血吸虫病孤立性非活动性患者血清中血管性血友病因子(vWF)、血管内皮生长因子(VEGF)、内皮素-1(ET-1)和内皮素-3(ET-3)的水平。患者分为两组:10例无门静脉高压患者(SM组)和18例有门静脉高压患者(PH组)。
两组患者血清白蛋白、VEGF和vWF水平无差异(P>0.05)。凝血酶原时间(INR)、血小板数量、脾脏大小、脾静脉直径和内皮素水平可区分PH组,该组ET-1水平降低(SM组=22.4±2.4 pg/ml,PH组=16.4±1.5 pg/ml;P=0.034),ET-3水平升高(SM组=2.1±0.1 ng/ml,PH组=3.2±0.1 ng/ml;P=0.000)。
在血吸虫病和门静脉高压(窦前型)患者中,VEGF和ET-1水平与肝硬化患者不同。